There is opportunity for orthopedic companies to create partnerships with surgeons, department leadership and executive administration. Three leaders share how.
Companies spoke about the need for navigation, robotics and AI at NASS 2024.
Outpatient surgery is the vanguard of modern healthcare and the future of surgical and medical innovation, says an ASC investor.
Tri-State Biologics will commercialize the RemeOs screw in the U.S. civilian hospital market.
J&J MedTech entered an exclusive U.S. commercial distribution agreement with Responsive Arthroscopy, enhancing its soft tissue portfolio.
The collaboration supports development and clinical deployment of OsteoSight, technology designed for the early identification of low bone mineral density.
The collaboration will promote Osteopore’s off-the-shelf products in Singapore for bone loss treatments in upper and lower extremities.
Anika plans to focus on its core hyaluronic acid technology and advance its differentiated Regenerative Solutions portfolio.
The exclusive agreement supports distribution of Novastep’s foot and ankle products across the UK, Ireland and Nordic regions.
JointVue’s patented OrthoSonic 3D Surgery Planning Technology is reportedly the only ultrasound device on the market to deliver 3D preoperative planning.
The collaboration enables distribution of OssiGraft™ and OssiGraft Prime cryopreserved viable bone matrix allografts through Enovis’ sales network.
There is opportunity for orthopedic companies to create partnerships with surgeons, department leadership and executive administration. Three leaders share how.
The partnership within the trauma product segment, related to the agreement signed in 2019, remains in effect.
Vertos Medical offers interventional pain management solutions for chronic lower back pain caused by lumbar spinal stenosis.
Companies spoke about the need for navigation, robotics and AI at NASS 2024.
The strategic agreement enables US distribution of Implanet’s Ultrasonic Bone Scalpel in endoscopic spine surgery.
The integration brings offerings for joint replacement, spine, trauma, sports medicine, robotics and more.
Biocomposites acquired the remaining shares in Laboratorios SL and Synergie Ingénierie Médicale, gaining full control of the SYNICEM and Subiton product ranges.
Login
Register for a free account
As a guest member you get access to more articles and videos every month.